Swedbank AB Boosts Stock Holdings in Henry Schein, Inc. $HSIC

Key Points

• Swedbank AB has increased its stake in Henry Schein, Inc. by 21.3%, acquiring an additional 155,207 shares for a total of 883,485 shares valued at approximately $60.5 million.
• Henry Schein's recent earnings report showed an EPS of $1.10, missing the consensus estimate of $1.19, despite revenue growth of 3.3% year-over-year.
• Analysts have mixed views on Henry Schein, with rating downgrades and a consensus target price of $76.67, indicating a majority hold rating among five buy ratings and seven hold ratings.

Swedbank AB boosted its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 21.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 883,485 shares of the company's stock after acquiring an additional 155,207 shares during the quarter. Swedbank AB owned 0.73% of Henry Schein worth $60,510,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in HSIC. Jane Street Group LLC lifted its position in shares of Henry Schein by 18.2% in the 4th quarter. Jane Street Group LLC now owns 25,556 shares of the company's stock worth $1,768,000 after purchasing an additional 3,932 shares during the period. Baird Financial Group Inc. lifted its position in shares of Henry Schein by 36.3% in the 4th quarter. Baird Financial Group Inc. now owns 5,438 shares of the company's stock worth $376,000 after purchasing an additional 1,447 shares during the period. Janus Henderson Group PLC lifted its position in shares of Henry Schein by 2.7% in the 4th quarter. Janus Henderson Group PLC now owns 10,709 shares of the company's stock worth $741,000 after purchasing an additional 286 shares during the period. Millennium Management LLC lifted its position in shares of Henry Schein by 451.7% in the 4th quarter. Millennium Management LLC now owns 497,554 shares of the company's stock worth $34,431,000 after purchasing an additional 407,376 shares during the period. Finally, OMERS ADMINISTRATION Corp lifted its position in shares of Henry Schein by 19.9% in the 4th quarter. OMERS ADMINISTRATION Corp now owns 5,403 shares of the company's stock worth $374,000 after purchasing an additional 895 shares during the period. 96.62% of the stock is owned by institutional investors.

Henry Schein Stock Up 1.9%

HSIC stock traded up $1.28 during midday trading on Thursday, reaching $68.65. 514,381 shares of the company's stock traded hands, compared to its average volume of 1,731,655. The company has a market cap of $8.33 billion, a price-to-earnings ratio of 22.14, a P/E/G ratio of 2.26 and a beta of 0.86. The firm's fifty day moving average price is $68.98 and its 200-day moving average price is $69.40. The company has a quick ratio of 0.78, a current ratio of 1.41 and a debt-to-equity ratio of 0.51. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). The firm had revenue of $3.24 billion for the quarter, compared to analysts' expectations of $3.22 billion. Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.Henry Schein's revenue was up 3.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.23 earnings per share. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. As a group, sell-side analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on the stock. UBS Group dropped their price target on shares of Henry Schein from $75.00 to $70.00 and set a "neutral" rating on the stock in a research report on Wednesday, August 6th. Barrington Research dropped their price target on shares of Henry Schein from $86.00 to $78.00 and set an "outperform" rating on the stock in a research report on Wednesday, August 6th. Baird R W downgraded shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 14th. Evercore ISI upgraded shares of Henry Schein from an "in-line" rating to an "outperform" rating and set a $83.00 price objective for the company in a research note on Tuesday, August 26th. Finally, Wall Street Zen lowered shares of Henry Schein from a "buy" rating to a "hold" rating in a research note on Sunday, September 7th. Five research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average price target of $76.67.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.